Tablets with mirabegron, a beta-3 agonist, address overactive bladder conditions in urology. Specialty drug manufacturers provide them to hospital pharmacies and outpatient clinics. Procurement specialists in healthcare organizations acquire these for therapeutic management in patient care protocols.